The outcomes from both AAV and Lentivirus studies concur that HNF-1β is pivotal in HD’s protective influence on the intestinal barrier, with HNF-1β-induced upregulation of DRA playing a key role in mitigating colitis-induced epithelial barrier deficiencies through HD treatment. The gene discussed is SLC26A3; the disease is Huntington disease.